ACA

Analyst Sentiment

Wall St. Consensus
Buy
8 analysts·Limited coverage
72
Score
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Rating Breakdown
Strong Buy
00%
Buy
788%
Hold
113%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$140.00
+12.8%
Consensus
$140.00
+12.8%
Bull
$140.00
+12.8%
12-Month Target Range8 analysts
$140.00$140.00$140.00
Current $124.14Consensus
Current Price
$124.14
Upside to Consensus
$15.86

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+6.71%
EPS+17.26%
FY2028
Rev+33.24%
EPS+43.58%

Earnings Surprises

Recent Analyst Actions

May 4, 2026Barclays
Arcosa price target raised to $140 from $115 at Barclays
Target:$140.00
+12.2%from $124.76
Nov 3, 2025Barclays
Arcosa price target raised to $115 from $106 at Barclays
Target:$115.00
+12.7%from $102.00
Oct 29, 2024Barclays
Arcosa initiated with an Overweight at Barclays
Target:$106.00
+11.1%from $95.42
Aug 7, 2024Stephens
Arcosa upgraded to Overweight at Stephens on benefits of portfolio actions
Target:$96.00
+23.6%from $77.70
Aug 5, 2024Loop Capital Markets
Arcosa price target raised to $110 from $95 at Loop Capital
Target:$110.00
+39.0%from $79.12
May 17, 2024D.A. Davidson
Arcosa price target raised to $110 from $105 at DA Davidson
Target:$110.00
+26.7%from $86.82
May 6, 2024D.A. Davidson
Arcosa (ACA) PT Raised to $105 at DA Davidson
Target:$105.00
+21.6%from $86.33
Aug 8, 2022Stephens
Stephens & Co. Maintains Overweight on Arcosa, Raises Price Target to $70
Target:$70.00
+11.5%from $62.79